GlobalData on MSN21d
FDA grants breakthrough status to Grin Therapeutics’ radiprodil
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Grin Therapeutics’ radiprodil for treating seizures associated with glutamate receptor, ionotropic, N-methyl D ...
Neurology Advisor8d
Radiprodil Gets Breakthrough Designation for Seizures Associated With Rare Gene Disorder
The FDA has granted Breakthrough Therapy designation to radiprodil for the treatment of seizures associated with GRIN-related neurodevelopmental disorder with GoF mutations.